QQ客服 官方微博 反馈留言

	Pretreatment of ghrelin protects H9c2 cells against hypoxia/reoxygenation-induced cell death via PI3K/AKT and AMPK pathways
	Chen, Yanbo; Wang, Honggang; Zhang, Yong; Wang, Zhengping; Liu, Shanshan; Cui, Lianqun
刊名	ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
	2019
卷号	47期号:1页码:2179-2187
关键词	Myocardial infarction cardioprotection apoptosis LDH release
DOI	10.1080/21691401.2019.1620253
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4547193
专题	山东大学
作者单位	1.Shandong Univ, Shandong Prov Hosp, Dept Cardiol, 324 Jingwuweiqi Rd, Jinan 250021, Shandong, Peoples R China. 2.[Chen, Ya
推荐引用方式 GB/T 7714	Chen, Yanbo,Wang, Honggang,Zhang, Yong,et al. Pretreatment of ghrelin protects H9c2 cells against hypoxia/reoxygenation-induced cell death via PI3K/AKT and AMPK pathways[J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY,2019,47(1):2179-2187.
APA	Chen, Yanbo,Wang, Honggang,Zhang, Yong,Wang, Zhengping,Liu, Shanshan,&Cui, Lianqun.(2019).Pretreatment of ghrelin protects H9c2 cells against hypoxia/reoxygenation-induced cell death via PI3K/AKT and AMPK pathways.ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY,47(1),2179-2187.
MLA	Chen, Yanbo,et al."Pretreatment of ghrelin protects H9c2 cells against hypoxia/reoxygenation-induced cell death via PI3K/AKT and AMPK pathways".ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 47.1(2019):2179-2187.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。